Gimme Care review: pricing, fine print, and how it ranks

The price, in words

Gimme Care offers tirzepatide but publishes no price we could capture; we track it as unpriced rather than guessing.

What the fine print says

Tracked in our universe; no price we could verify at capture.

Pharmacy & transparency

Price evidence: No price published, last verified 2026-08-05. The dispensing pharmacy is not named publicly — the single most common transparency gap in this market. Ask which pharmacy fills the prescription, whether it is 503A or 503B, and whether a certificate of analysis is available; our pharmacy guide explains what each answer means.

Nearest alternatives at this price point

Shopping the immediate neighborhood, the closest verified substitutes are NexLife at $215 (flat at every dose, no membership, named pharmacy); Yucca Health at $258 (flat at every dose, no membership, prepaid to $225); IVIM Health at $278 (source-verified) — each linked matchup runs the full head-to-head arithmetic on this exact question.

State availability

Gimme Care publishes availability of: not published. State-by-state context, exceptions, and city coverage live in the 51-state cost guides.

Five questions before checkout

Whatever the marketing says, get answers to: (1) the current all-in monthly price, in writing, since no verifiable figure is published; (2) whether the price changes at any rung of the dose ladder, and the exact tier schedule; (3) which pharmacy, by name, fills the prescription — and whether it's 503A or 503B, licensed for your state, with a certificate of analysis available; (4) the cancellation mechanics — deadline relative to renewal, written-confirmation availability, and whether any membership cancels separately. A program that answers all five plainly has already told you most of what this review can.

Bottom line

Until Gimme Care publishes verifiable pricing, treat any quoted figure as unconfirmed and get it in writing. For context, the verified market floor is $215/mo compounded tirzepatide and $133/mo compounded semaglutide, with brand Zepbound at $449/mo and Wegovy at $349/mo at maintenance.